Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows provided by operating activities:
Net income	$ 2,207	$ 1,328
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	239	234
Amortization of operating lease right-of-use assets	341	338
Stock based compensation	44
Change in deferred tax assets	(101)	49
Realized gain on sale of iBio, Inc. shares	(49)
Unrealized (gain) loss on investments	(35)
Other, net	11	50
Changes in operating assets and liabilities:
Accounts receivable	166	(1,161)
Inventories	(1,247)	(2,807)
Other current assets	(7)	(29)
Security deposits and other assets	(4)	(3)
Accounts payable	2,256	1,852
Accrued expenses and other liabilities	71	189
Operating lease obligations	(343)	(339)
Net cash provided by (used in) operating activities	3,549	(299)
Cash flows from investing activities:
Purchase of property and equipment	(158)	(350)
Proceeds from sale of investment	85
Proceeds from sale of machinery and equipment	3
Cash contribution in AgroSport LLC		(8)
Net cash used in investing activities	(70)	(358)
Cash flows from financing activities:
Advances under revolving credit facility	35,190	35,574
Proceeds from sales/lease back of equipment		233
Proceeds from exercise of employee stock options		24
Repayments of advances under revolving credit facility	(37,599)	(34,322)
Repayments under term note payables	(823)	(475)
Repayments under finance lease obligations	(157)	(174)
Net cash (used in) provided by financing activities	(3,389)	860
Net increase in cash	90	203
Cash at beginning of period	475	228
Cash at end of period	565	431
Supplemental disclosures of cash flow information:
Interest paid	323	568
Income taxes paid	$ 303	$ 193